
@SinaiMSW @MountSinaiGI - #motility, #DGBI & women’s health.
Manhattan, NY
Joined January 2011
- Tweets407
- Following497
- Followers742
- Likes4.3K
Yuying Luo retweeted
Important and much anticipated RCT of therapist-delivered vs. smartphone-delivered gut-directed hypnotherapy in #IBS from @IBS_Maastricht now published online in @Gut_BMJ
gut.bmj.com/content/early/20…
Yuying Luo retweeted
🌟Hot off the press! Our newest special issue introduces an enhanced global conceptualization of disorders of gut–brain interaction from the Rome Foundation.
📖Browse the issue here: ow.ly/qivv50YO5r0
#GutBrainAxis #Neurogastroenterology #DGBI
Yuying Luo retweeted
Functional GI disorders including abdominal pain and IBS are more common in women. This review in @UEGJournal explains why.
📸: onlinelibrary.wiley.com/doi/…
One of the best experiences I’ve had thanks to the @AmCollegeGastro! @IBS_Maastricht
🌎ACG International Training Grants🌍 offer a unique opportunity to expand your clinical or research expertise through advanced training in GI or hepatology, outside your country of practice.
Apply by Wednesday, April 15
🛬 gi.org/gi-training-grants
@KeneChudyMD
📢 Call for #IBS survey participants 📢
Proud to partner with Drs. Laurie Keefer & Yuying Luo at Mount Sinai to better understand the journey experienced by patients with IBS as they seek medical care.
All responses are anonymous and confidential. Learn more and consider joining: survey.co1.qualtrics.com/jfe…
Yuying Luo retweeted
🚨Thrilled to welcome the new #EditorialTeam at @NGMJournal led by our new Editor-in-Chief, Prof. Daniel Keszthelyi @IBS_Maastricht🎉
📢We look forward to great science & fascinating breakthroughs ahead in #Neurogastroenterology & #Motility #GutBrainScience
@ANMSociety @esnm_eu
Yuying Luo retweeted
We’re honored to welcome Laurie Keefer, PhD as Chief Executive Officer of the Rome Foundation. An internationally recognized leader in gut–brain care and Chair of our GastroPsych Group, her leadership reflects the future of our mission. Congratulations, Dr. Keefer!
Excited to share our 🔓review in @UEGJournal: "A Roadmap for Advancing Women's Health in Disorders of the Gut-Brain Interaction"
onlinelibrary.wiley.com/doi/…
📌Improving women's health in #DGBI will require clinical trials that intentionally account for hormonal influences on symptoms &treatment outcomes, inclusion of sex-specific comorbidities, and cross-disciplinary trial designs that address overlapping symptoms.
Yuying Luo retweeted
⭐️Upper gastrointestinal symptoms are often caused by lower gastrointestinal dysfunction
Check out our latest study where we find that constipation and pelvic floor dysfunction are associated with impaired gastric emptying and accommodation!
onlinelibrary.wiley.com/doi/…
#GITwitter
Yuying Luo retweeted
🆕🔥The Path Forward: Assessing a Pilot Competency-Based Curriculum on #DGBIs for Gastroenterology Trainees‼️
👉onlinelibrary.wiley.com/doi/…
✅DGBI education curriculum
✅Pre-&Post-individual knowledge scores
🎯Attitudes in managing DGBIs👏
@ANMSociety @esnm_eu @MountSinaiGI @yuyingMD
Yuying Luo retweeted
Implications of the Updated Lyon Consensus 2.0 in Clinical Practice
📕Read Here: journals.sagepub.com/doi/abs…
@mako_koseki @DrEmilySeltzer @KCavaliereMD @yuyingMD @DJodorkovskyMD @MountSinaiGI @SinaiMSW @MountSinaiNYC @ForegutSociety
#SurgTwitter #MedX #GIX #SurgX #endoscopy
Yuying Luo retweeted
The International Foundation for Gastrointestinal Disorders (@IFFGD) along with the American Neurogastroenterology and Motility Society (ANMS) are launching a letter-writing campaign to the members of Congress asking them to urge the FDA to find a resolution for patients to continue accessing domperidone.
Seeing more ED visits for #constipation lately? Better outpatient management (by PCPs and GIs) needed!
👏 work led by @msm_msw PGY3 Swati Patel (presented at #ACG2024) highlighted by @gastroendonews
Only one-third of patients visiting an ED for constipation were taking appropriate medications before their visit, a recent study found.@swatigp
gastroendonews.com/PRN/Artic…
Yuying Luo retweeted
Congrats to @yuyingMD representing @MountSinaiNYC at @ACG Early Career Leadership Prorgram. The future is indeed bright!
The #FutureofGI is bright with the 🌠 rising stars in the 2025 Early Career Leadership Program!
Thank you, #ECLP, for advocating for GI physicians and patients at #ACGAdvocacyDay2025 & your commitment to growing your leadership skills. Keep shining! #ACGfamily
I always get asked whether it’s ok to use TCAs in patients with IBS-C (yes, as long as stool burden is controlled!) - great to see this data.
⭐️ Amitriptyline did not worsen bowel symptoms, and was well-tolerated, irrespective of #IBS subtype.
#IBSAwarenessMonth
Excellent #GUTBlog by Professor Alexander Ford @alex_ford12399 on the paper
"Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial" via
bit.ly/4iVXpn2
Paper via bit.ly/3YebfZz
#IBS #ATLANTISTrial @GastroRes_Leeds @AtlantisTrial
Yuying Luo retweeted
#ACGAdvocacyDay2025 is underway! The ACG Governors and Early Career Leadership Program #ECLP are off to meet with Members of Congress. A top priority: addressing burdensome prior authorization requests that lead to delays in care.
Yuying Luo retweeted
Truly an honor advocating for our patients and colleagues at the Capitol Hill as part of the New York Governors and young leaders!! #ACGAdvocacyDay2025 @AmCollegeGastro
Great discussion and Q&A session today with @motilitymorgan @AroniadisC & others on #constipation beyond guidelines as part one of Rome Partner's educational webinar series!
Join Rome Partners (free!): bit.ly/4gwsVWR
#HappeningNow coffee with the Rome Foundation Partners. Are you watching the webinar? Like & comment below. If you missed it, rest assured that we will make the video available via on demand learning in June. Details to come. #constipation #IBS #Gastroenterologists #PrimaryCare







































